Abstract:SH2B1 deficiency induces obesity and metabolic disease in mice and humans. SH2B1‐expressing neurons in the PVH and a PVHSH2B1→DRN neurocircuit are uncovered here. Activation of the PVHSH2B1→DRN neurocircuit suppresses appetite. SH2B1 directly enhances BDNF signaling in PVHSH2B1 neurons, thereby increasing the ability of the PVHSH2B1→DRN neurocircuit to defend against energy imbalance, obesity, and metabolic disease. SH2B1 mutations are associated with obesity, type 2 diabetes, and metabolic dysfunction‐associated steatotic liver disease (MASLD) in humans. Global deletion of Sh2b1 results in severe obesity, type 2 diabetes, and MASLD in mice. Neuron‐specific restoration of SH2B1 rescues the obesity phenotype of Sh2b1‐null mice, indicating that the brain is a main SH2B1 target. However, SH2B1 neurocircuits remain elusive. SH2B1‐expressing neurons in the paraventricular hypothalamus (PVHSH2B1) and a PVHSH2B1→dorsal raphe nucleus (DRN) neurocircuit are identified here. PVHSH2B1 axons monosynaptically innervate DRN neurons. Optogenetic stimulation of PVHSH2B1 axonal fibers in the DRN suppresses food intake. Chronic inhibition of PVHSH2B1 neurons causes obesity. In male and female mice, either embryonic‐onset or adult‐onset deletion of Sh2b1 in PVH neurons causes energy imbalance, obesity, insulin resistance, glucose intolerance, and MASLD. Ablation of Sh2b1 in the DRN‐projecting PVHSH2B1 subpopulation also causes energy imbalance, obesity, and metabolic disorders. Conversely, SH2B1 overexpression in either total or DRN‐projecting PVHSH2B1 neurons protects against diet‐induced obesity. SH2B1 binds to TrkB and enhances brain‐derived neurotrophic factor (BDNF) signaling. Ablation of Sh2b1 in PVHSH2B1 neurons induces BDNF resistance in the PVH, contributing to obesity. In conclusion, these results unveil a previously unrecognized PVHSH2B1→DRN neurocircuit through which SH2B1 defends against obesity by enhancing BDNF/TrkB signaling.

Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.

Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.

Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase.

Shp2 Acts Downstream of Sdf-1 Alpha/Cxcr4 in Guiding Granule Cell Migration During Cerebellar Development

Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals.

Nonreceptor Tyrosine Phosphatase Shp2 Promotes Adipogenesis Through Inhibition of P38 MAP Kinase.

SH2B1 Defends Against Energy Imbalance, Obesity, and Metabolic Disease via a Paraventricular Hypothalamus→Dorsal Raphe Nucleus Neurocircuit

Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice.

Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment

Conditional Deletion Of Shp2 Tyrosine Phosphatase In Thymocytes Suppresses Both Pre-Tcr And Tcr Signals

Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease

[Molecular Mechanism of SH2B1 in Regulating JAK2/IRS2 During Obesity Development].

Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis.

The Shp-2 tyrosine phosphatase

Coordinated Regulation by Shp2 Tyrosine Phosphatase of Signaling Events Controlling Insulin Biosynthesis in Β‐cells

Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells

Loss of Shp2 Phosphatase Favors Alternative Activation of Macrophages, Contributing to Pulmonary Fibrosis in Mice

Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice.

SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin

Disrupting Phosphatase SHP2 in Macrophages Protects Mice from High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance by Elevating IL-18 Levels

Shp2 is dispensable in the formation and maintenance of the neuromuscular junction.